These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1897019)
1. Treatment of corneal allograft rejection with the cytotoxin IL-2-PE40. Herbort CP; de Smet MD; Roberge FG; Nussenblatt RB; FitzGerald D; Lorberboum-Galski H; Pastan I Transplantation; 1991 Sep; 52(3):470-4. PubMed ID: 1897019 [TBL] [Abstract][Full Text] [Related]
2. [An experimental study of corneal allograft rejection with cytotoxin IL-2-PE40]. Wu J; Zhou G Zhonghua Yan Ke Za Zhi; 1995 Sep; 31(5):370-3. PubMed ID: 8706588 [TBL] [Abstract][Full Text] [Related]
3. Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis. Roberge FG; Lorberboum-Galski H; Le Hoang P; de Smet M; Chan CC; Fitzgerald D; Pastan I J Immunol; 1989 Dec; 143(11):3498-502. PubMed ID: 2511243 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response. Volk HD; Müller S; Yarkoni S; Diamantstein T; Lorberboum-Galski H J Immunol; 1994 Sep; 153(6):2497-505. PubMed ID: 8077661 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli. Lorberboum-Galski H; FitzGerald D; Chaudhary V; Adhya S; Pastan I Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1922-6. PubMed ID: 3126499 [TBL] [Abstract][Full Text] [Related]
6. IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptors. Ogata M; Lorberboum-Galski H; FitzGerald D; Pastan I J Immunol; 1988 Dec; 141(12):4224-8. PubMed ID: 3264309 [TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of the gene coding for IL-2(60)-PE40, a molecular targeted protein. Zhang M; Zhao X; Li H; Lu S Chin Med Sci J; 1995 Sep; 10(3):136-40. PubMed ID: 8580481 [TBL] [Abstract][Full Text] [Related]
8. Cardiac allograft survival in mice treated with IL-2-PE40. Lorberboum-Galski H; Barrett LV; Kirkman RL; Ogata M; Willingham MC; FitzGerald DJ; Pastan I Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1008-12. PubMed ID: 2644640 [TBL] [Abstract][Full Text] [Related]
9. Suppression of allograft rejection with anti-alphabeta T cell receptor antibody in rat corneal transplantation. Yamagami S; Tsuru T; Ohkawa T; Endo H; Isobe M Transplantation; 1999 Feb; 67(4):600-4. PubMed ID: 10071034 [TBL] [Abstract][Full Text] [Related]
10. Administration of IL-2-PE40 via osmotic pumps prevents adjuvant induced arthritis in rats. Improved therapeutic index of IL-2-PE40 administered by continuous infusion. Lorberboum-Galski H; Lafyatis R; Case JP; FitzGerald D; Wilder RL; Pastan I Int J Immunopharmacol; 1991; 13(2-3):305-15. PubMed ID: 2071302 [TBL] [Abstract][Full Text] [Related]
13. Penetrating keratoplasty in the rat: a model for the study of immunosuppressive treatment of graft rejection. Herbort CP; Matsubara M; Nishi M; Mochizuki M Jpn J Ophthalmol; 1989; 33(2):212-20. PubMed ID: 2474684 [TBL] [Abstract][Full Text] [Related]
14. Use of topical FK506 in a corneal graft rejection model in Lewis rats. Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986 [TBL] [Abstract][Full Text] [Related]
15. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway". Sano Y; Streilein JW; Ksander BR Transplantation; 1999 Oct; 68(7):963-70. PubMed ID: 10532535 [TBL] [Abstract][Full Text] [Related]
16. Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats. Case JP; Lorberboum-Galski H; Lafyatis R; FitzGerald D; Wilder RL; Pastan I Proc Natl Acad Sci U S A; 1989 Jan; 86(1):287-91. PubMed ID: 2492102 [TBL] [Abstract][Full Text] [Related]
17. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin. Puri RK; Ogata M; Leland P; Feldman GM; FitzGerald D; Pastan I Cancer Res; 1991 Jun; 51(11):3011-7. PubMed ID: 2032239 [TBL] [Abstract][Full Text] [Related]
18. [Effect of cytotoxin interleukin-2-pseudomonas exotoxin 66 on corneal allograft rejection in mice]. Wu J; Yu J Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2152-5. PubMed ID: 19923053 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of rejection of orthotopic corneal allografts in the rat. Callanan D; Peeler J; Niederkorn JY Transplantation; 1988 Feb; 45(2):437-43. PubMed ID: 3278439 [TBL] [Abstract][Full Text] [Related]
20. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]